Bacteriophage therapeutics market Share, Growth Analysis by 2035

I am Michaeljohnson (mj5494470@gmail.com). I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via mj5494470@gmail.com email.

Disclaimer: The domain owner, admin and website staff of New York City US, had no role in the preparation of this post. New York City US, does not accept liability for any loss or damages caused by the use of any links, images, texts, files, or products, nor do we endorse any content posted in this website.

With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.

One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.

The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:

• Type of Therapeutic Area
• Infectious Diseases
• Oncological Disorders
• Other Disorders
• Distribution by Route of Administration
• Oral Route
• Rectal Route
• Intravesical Route
• Topical Route

• Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and North Africa

The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:

• Adaptive Phage Therapeutics
• ContaFect
• Eliava BioPreparations
• Micreos
• NPO Microgen
• Phagelux
• Pherecydes Pharma

Table of Content

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE

5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE

6. COMPANY AND DRUG PROFILES

7. CLINICAL TRIAL ANALYSIS

8. PATENT ANALYSIS

9. PUBLICATION BENCHMARKING ANALYSIS

10. ACADEMIC GRANTS ANALYSIS

11. FUNDING AND INVESTMENT ANALYSIS

12. PARTNERSHIPS AND COLLABORATIONS

13. START-UP HEALTH INDEXING

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com